AstraZeneca COVID-19 Vaccine Protects More Against Delta, Kappa Variants Like Pfizer techtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from techtimes.com Daily Mail and Mail on Sunday newspapers.
I don t want to die! Macron s AstraZeneca farce has patients running away from jab Tim McNulty
Replay Video UP NEXT
The French President has made repeated claims regard the safety of the anglo-Swedish vaccine, statements which have been blamed for mounting skepticism in Europe about the risk associated with receiving an injection of AstraZeneca. It comes after medical authorities across a number of European states reported cases of blood clots in a number of people who had got the job. RT has reported the situation has reached the point where residents are running away when presented with the Oxford manufactured drug.
Australians over the age of 50 will have access to the coronavirus vaccine after National Cabinet agreed to bring forward the next stage of the country s COVID-19 roll out.
Prime Minister Scott Morrison confirmed the changes in a statement this evening following the first emergency meeting of National Cabinet. National Cabinet agreed in-principle to a series of changes to the Australian COVID-19 Vaccination Strategy that will be put forward for approval at the next meeting of National Cabinet including options to bring forward the commencement of vaccinations for over 50-year-olds under the Australian COVID-19 Vaccination Strategy priority group 2a, Mr Morrison said in the statement.
Coronavirus patients much more likely to get blood clots than vaccine recipients
People who actually catch coronavirus are nine times more likely to develop these particular types of blood clots than people who get the AstraZeneca vaccine. When we look at what is happening with people who have been admitted to hospital throughout the whole pandemic, 16 per cent of people have had a clot of some sort related to their COVID disease, Chief Medical Officer Paul Kelly said. So clotting is a feature of COVID. It also happens to be a feature, very rarely, of this AstraZeneca vaccine.
READ MORE:
We were looking at rolling out the mass vaccination perhaps later on in the plan, he said. GP clinics were always going to be the focus of the 1B rollout and then pharmacists were going to join on board.
Dr Bartone said the mass hubs would rely on robust supply and availability , necessitating a build-up of AstraZeneca vaccines and the incoming 20 million Pfizer doses. But 1B is GP-led, and that s where patients want to go, he said.
Doctors have said mass hubs will not service older Australians well.(Getty) (Mass vaccination hubs) are an important part as we get into phase 2B and the younger population which are much more mobile and don t have that immediate access to general practice in a routine.